Transplant of marginal/NHBD kidneys and outcomes: kidney David Talbot.

Slides:



Advertisements
Similar presentations
Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,
Advertisements

Blood pressure control in children following kidney transplantation in the UK Manish Sinha Evelina Childrens Hospital London UKRR and NHS Kidney Care Audit.
L. Szabo P. Laftsidis E. Ablorsu Cardiff Transplant Unit Cardiff UK HYPOTHERMIC MACHINE PERFUSION IMPROVES OUTCOMES IN DCD KIDNEYS.
THE PATIENT’S JOURNEY TO TRANSPLANT AND BEYOND
UNOS Region 8 MELD29 Trial Analysis of the Results
THE IMPORTANCE OF PUBLISHING NEGATIVE FINDINGS Rolofylline, an Adenosine A1 – Receptor Antagonist, in Acute Heart Failure Barry M. Massie et al The New.
Supporting the Neonatal and Pediatric Donor Breakout Session A Presenters: Jeffrey Johnson, MD, LAC + USC Medical Center Mudit Mather, MD, Loma Linda University.
Implementation of new technologies Dr Keith Cooper Southampton Health Technology Assessments Centre University of Southampton.
18 th TPM course, November 2012 Maastricht Classification of DCD DefinitionWhere IDead on arrival Spain, France, Italy IIUnsuccessful resuscitation III.
30-Year Retrospective on Organ Transplant Immunosuppression in the Era of Calcineurin Inhibitors Herwig-Ulf Meier-Kriesche, MD Professor of Medicine Department.
Perfusion fluids Cost and Economics Dr.R.V.Raghavendra Rao M.S,M.Ch(SGPGI),FHPB,FLT(SNUH) Consultant Surgical Gastroenterologist and Liver Transplantation.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Horizon Scanning on organ perfusion
Facing the Organ Shortage Crisis: Business as Usual vs Non- Conventional Solutions? Richard Perez MD Division of Transplant Surgery UC Davis Medical Center.
Harefield DCD heart transplant programme
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.
Taskforce Implementation – Progress and Results Chris Rudge FRCS National Clinical Director for Transplantation Renal CDs Meeting 12 March 2010.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
Organ Donation in DCD: 10 Year Experience at the University of Michigan A Rojas-Pena, MD; L Sall, BS; K. Koch, BS; E Cooley, RN; M Gravel, RN; R Bartlett,
David C. Mulligan, MD, FACS
“NHSBT strategic vision meeting” Dr. Les Russell - October Tel +44 (0) Confidential to OrganOx.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
Comparison of HTK and UW in Abdominal Transplantation Dr. Richard S. Mangus, MD MS Indiana University, School of Medicine.
Background The renewed interest in DCD started since the 1990s following the persistent organ shortage from donation after brain death (DBD) and the short-
Strategies for Maximizing Outcomes in Liver Transplantation James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee.
Short and Long term function and survival of other graft harvested as part of a multiorgan procurement including the intestine Farinelli P, Troncoso J,
Brain Death in The ICU Dr. Jonathan Goodall M62 Coloproctology Course March 22 nd 2007.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
New Perspective for Expanding Donor’s Pool - Resuscitation Kidney In Uncontrolled Donors by Normothermic Perfusion “In Situ” with Oxygenation and Leucocyte.
Renal transplantation from non-heart beating donors
Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.
Organ Donation and Transplantation in Paediatrics.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
3 Patrick T Anderson, 2,3 Vivian McAlister, 1,3 Alp Sener, 1,3 Patrick P Luke Divisions of 1 Urology and 2 Surgery, Department of Surgery, 3 Schulich School.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
During the study period 53 retrievals for MVIT were completed, all of which were performed by a Consultant Transplant surgeon. The median distance from.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
Ante mortem interventions in DCD Dr Malcolm Watters Regional Clinical Lead for Organ Donation 1.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
UC Davis Medical Center
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
Can we improve deceased donor kidney utilisation? Chris Callaghan National Clinical Lead for Abdominal Organ Utilisation, NHSBT Consultant Transplant Surgeon,
New kidney offering scheme … Lorna Marson Deputy Chair, Kidney Advisory Group Work in progress.
National Histopathology Service for Transplantation
Improving Outcomes in DCD Renal Transplantation Reference: Hoogland ERP, Snoeijs MGJ, van Heurn LWE. DCD kidney transplantation: Results and measures to.
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
The ALERT Trial.
BUONA FUNZIONE RENALE DEI TRAPIANTI RENALI DA DONATORI ANZIANI VALUTATI CON CLEARANCE DELLA CREATININA SECONDO GAULT-COCKCROFT, CON DATI ECOGRAFICI E CON.
Strategies to increase transplantation
Kidney Transplantation.
Enterprise | Interest Nothing to disclose.
Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
Liver only transplants in the UK Question 2: In terms of survival benefit.
Liver transplantation using Donation after Cardiac Death donors
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Number of Donors in Australia
Presentation transcript:

Transplant of marginal/NHBD kidneys and outcomes: kidney David Talbot

The increasing use of NHBD kidneys

DBD and DCD kidney transplants by centre, 2008/2009 financial year

Kidney transplant outcomes for DBD/DCD donors Graft survival DCD DBD Patient survival

Standard and Expanded Criteria donors: Standard donor: donors 10-39yrs, no hypertension, no CVA, terminal serum creatinine< 133μmol/l Expanded donor: >60 or of the above (producing a relative risk >1.7) (Am J Trans 2002; 2:1. Transplantation 2002; 74:1281. Am J T 2003; 3:114. Ann Surg 2004; 239: 688.) Where does DCD/NHBD lie in relation ship to expanded versus standard donors?

UNOS data: 2562 DCD 62,800 Standard criteria(<50) 12,812 Expanded Criteria donor

Standard versus expanded versus DCD:

Unified donor retrieval teams from 1 st April with a desire to share NHBD kidneys (NHS BT) Unification means that there is a need for consensus: How long do we wait after withdrawal of support? Should we use an Apnoea score? Machine versus static cold storage? Is prolonged cold ischaemia safe for DCD/NHBD kidneys? Which kidneys can be shared?

How long to wait after withdrawal?

New England Organ bank: Oct 99-April kidneys 39 livers *Small numbers, best donors, short time between extubation and death but suggestion that primary function in kidneys better if hypotensive period is short: (confirmed with composite end points of the liver) though no difference to long term outcome for the kidney *NB Dominic Summers GFR DCD versus DBD equivalent though higher at 3/12

Newcastle team call outs in

Wisconsin Apnoea Score: Chapter 15 Donors without a heart beat in the US- Anthony D’Alessandro from Organ donation and transplantation after cardiac death (DT/ADA ISBN )

CriteriaAssigned pointsScore Spontaneous resps after 10mins Rate >12 Rate <12 TV>200cc TV<200cc NIF>20 NIF< No spontaneous resps9 BMI: < >303 No vasopressors1 Single vasopressors2 Multiple vasopressors3 Patient age: Endotracheal tube3 Tracheostomy1 Oxygenation after 10 mins>90% 80-89% <79% Final score/47

Wisconsin Apnoea score: 8-12: High risk of continuing to breathe after extubation Moderate risk for continuing to breathe after extubation Low risk for continuing to breathe after extubation 84.3% accurate of death within 2 hours Wisconsin sends a team if score >12

?Evaluate a UK score CriteriaAssigned pointsScore No spontaneous resps9 BMI: < >303 No vasopressors1 Single vasopressors2 Multiple vasopressors3 Patient age: CPAP?9 Endotracheal tube3 Tracheostomy1 Final score/40

Risk of continuing to breath on withdrawal High risk: Tracheostomy, no inotropes, young, thin, spontaneous breathing -4 Moderate risk: bmi 25-29, single inotrope,31-50 years of age, intubated, spontaneous breathing- 9 Low risk 1: High bmi, multiple inotropes, 51+, endotracheal tube, no spontaneous breathing- 21 Or Low risk: High BMI, 51+, no inotropes, CPAP- 16

Machine versus static storage Is machine perfusion with GST etc needed for viability assessment? Is machine perfusion better than static storage for marginal kidneys? Does machine perfusion confer some benefit when kidneys are exchanged?

Newcastle NHBD Donor numbers Maastricht IIMaastricht IIIMaastricht IV Donor number35222 Kidneys used31344 Proportion used44%79%100% Proportion kidney transplants of total 44.9%49.3%5.8%

Newcastle versus Bristol NHBD MIII- BTS 2007 Vijayanand collected data on MIII renal transplants : SCS=Bristol, HMP= Ncl

Bristol versus Newcastle

Others Oxford/Plym/New p = 0.39 (logrank) Dominic Summers NHS BT 2010 UK outcome machine versus cold. Units that ‘do’ versus units that don’t. Censoring out those involved in UK MPS/static storage

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation Cyril Moers, Jacqueline M Smits, Mark-Hugo J Maathuis, Jurgen Treckmann, et al. The New England Journal of Medicine. Boston: Jan 1, Vol. 360, Iss. 1; pg. 7 The New England Journal of MedicineJan 1, 2009

The Blue kidney at retrieval: Ray et al NEJM April 2009; 360: kidneys from 19 donors usually femoral cannulation, Maastricht II or misplaced cannulae. Blue at explant despite flushing. Machine perfusion: kidneys improved 34 transplanted with reasonable outcomes- 10 dual, 14 single kidney transplants

Use/non use of kidneys from NHBD’s by unit: (highlighted units not using mps)

Units not using machine perfusion (April ) Total% Donors193 Kidneys retrieved 381 (total potential: ?386) 98.7% Kidneys used %

Use rate between machine perfusion sites (April ) OxfordPlymouthNewcTotal Donors Kidneys retrieved Kidneys used % used * *: Chi square versus other centres

Cold ischaemia after primary warm ischaemia Widely held that DCD organs extra- sensitive to damage by cold ischaemia Dominic Summers on NHS BT data of 748 DCD kidneys increased failure with: Old donors (>60 hazard ratio 2.3, p=0.001) Old recipients (>60 hazard ratio 2.03, p=0.01) Cold ischaemia (>12 hours hazards ratio 1.9 p=0.06)

% DGFNo crossmatch Crossmatchprobability DBD18%28%0.03 DCD54%52%NS Dominic Summers NHS BT data Suggests minimising cold ischaemia is critical Abstract number 0094

In summary DCD versus DBD kidneys same outcome survival/gfr of MIII donors Agonal period- how long- short for liver, kidney can be long (with DGF but no consequence on long term outcome) To minimise excessive call outs a form of ‘apnoea’ test could be employed by a national retrieval team

In summary-2 Machine perfusion for kidneys after NHBD not essential for MIII donors Outcome improved by MPS according to the European trial Non use rate of kidneys is higher with static storage of the order of 10% Cold ischaemia should be minimised for kidneys particularly NHBD

Sharing NHBD kidneys, which donor? which kidney? Meeting Standard donor: donors 10-39yrs, no hypertension, no CVA, terminal serum creatinine< 133μmol/l Short agonal period (short period whilst BP<60)- (max ?1 hour- same as liver) Short period asystolle to perfusion (max ?30mins) Aortic cannulation rather than femoral Kidney pale and well flushed on retrieval Experienced retrieval surgeon UW flush after initial low viscosity flush Marshals or HTK Machine perfusion would give some security to the receiving centre Transplant unit should not be too far from donor unit Recipient transplanted with a virtual crossmatch to minimise cold ischaemia

Non sharing of NHBD kidneys but national retrieval team: Meeting All other donors than standard: (older donors, hypertension, CVA, terminal serum creatinine> 133μmol/l) Longer agonal period permitted ?4/5 hours Short period asystolle to perfusion (max ?45mins) Aortic or femoral cannulation but aortic preferable Local judgement as to kidney use Machine perfusion or static according to local preference as local unit will be using them Minimise cold ischaemia ?virtual crossmatch

Immunosuppression post renal transplant after DCD Schadde et al Transplant Int 2008;21:625 campath v atg v Il2Rab- similar outcomes slightly higher infection with campath Sanchez-Fructuoso Trans Int 2005; 18: 596 best with antiIl2rAb, low dose tacr, mmf and steroids Wilson BJS :681 anti Il2r, mmf and pred with delayed tacr

Oxford/Plym/New Cold Oxford/Plym/New machperf Others Cold storage Others Mach perf n=18 p = 0.78 Kaplan-Meier of 5yr Graft survival (all-cause graft loss) Dominic Summers NHS BT 2010